Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
Rhea-AI Summary
Daré Bioscience (NASDAQ: DARE) will host a corporate update conference call and webcast at 4:30 PM Eastern Time on Thursday, August 13, 2026, to review second-quarter 2026 financial results and provide a company update. Investors can join by phone using conference ID 3808585 or via the Investors section of the company’s website, where the live webcast and a 90-day replay will be available.
Positive
- None.
Negative
- None.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 07 | financial results call | Neutral | -7.9% | Scheduled Q1 2026 results review and company update via conference call |
| Mar 20 | financial results call | Neutral | +4.6% | Scheduled full-year 2025 results review and company update via webcast |
| Nov 06 | financial results call | Neutral | -1.6% | Scheduled Q3 2025 results review and company update via webcast |
| Aug 07 | financial results call | Neutral | -9.7% | Scheduled Q2 2025 results review and company update via conference call |
| May 06 | financial results call | Neutral | -4.0% | Scheduled Q1 2025 results review and company update via conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Comparable scheduling announcements produced four declines and one gain, with an average 24-hour move of -3.72%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that it will host a corporate update conference call and webcast at 4:30 PM Eastern Time on Thursday, August 13, 2026, to review its financial results for the quarter ended June 30, 2026 and to provide a company update.
To access the conference call via phone, dial (646) 307-1963 or (800) 715-9871 (toll-free). The conference ID number for the call is 3808585. The live webcast can be accessed under “Presentations, Events & Webcasts" in the Investors section of the company's website at ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. The webcast will be archived in the same section of the company's website and available for replay for 90 days.
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré is working to change that. Learn more at darebioscience.com.
Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Source: Daré Bioscience, Inc.
